+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neuroscience Antibodies and Assays Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4987065
  • Report
  • February 2020
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abcam Plc
  • BioLegend, Inc
  • Bio-Rad Laboratories, Inc
  • F. Hoffmann-La Roche
  • GenScript
  • Thermo Fisher Scientific
  • MORE
The Neuroscience Antibodies and Assays Market is expected to register a CAGR of around 10.2% during the forecast period. Neuroscience research relies heavily on antibodies that help in identify and elucidate reactions on the cellular, molecular, and biochemical level, which may lead to a better understanding of a variety of neuroscience processes and neuronal diseases. Antibody-based approaches are the most critical and widely used techniques in molecular and cellular neuroscience, leading to rapid development in our knowledge of protein abundance, distribution, structure, and function.

The World Health Organization (WHO), estimates that neurological disorders can affect up to one billion people worldwide. Common neurological disorders, such as epilepsy, multiple sclerosis, Parkinson’s disease, stroke, and traumatic brain injuries are major public health problems that affect both developed and developing countries. According to Global Burden of Disease (GBD)/Institute for Health Metrics and Evaluation, globally in the year 2016, neurological disorders were the leading cause of disability-adjusted life year (DALY) approximately 276 million and a second leading cause of deaths approximately 9 million. According to the World Health Organization (WHO), estimated that the number of patients with neurological diseases will rise from 95 million in the year 2015 to 103 million by the year 2030. Rising incidence of neurological diseases, increasing research and development activities and growth in the pharmaceutical and biotechnology industries are the key driving factors in the nephrostomy devices market.

Key Market Trends

Immunoassays Segment is Expected to Hold a Major Market Share in the Neuroscience Antibodies and Assays Market

Immunoassays are chemical tests that measure the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Immunoassays are widely used techniques in different areas for the diagnosis of diseases, therapeutic drug monitoring and also in pharmacokinetic and bioequivalence studies in drug discovery and development. According to World Health Organization (WHO), hundreds of millions of people globally are affected by neurological disorders among them more than 50 million people affected with epilepsy and around 47 million people are affected by dementia globally.
Immunoassays segment holds a significant market share in the neuroscience antibodies and assays market and is anticipated to show a similar trend over the forecast period due to the development of novel antibodies, technological developments in immunoassays, and increasing government initiatives in the genomics and proteomics research field. Rising incidence of neurological diseases, technological developments in immunoassays and increasing research and development activities are the key driving factors in the immunoassays segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global neuroscience antibodies and assays market due to rising incidence of neurological diseases, increasing research and development activities and growth in the pharmaceutical and biotechnology industries in this region. According to Centers for Disease Control and Prevention (CDC), in the year 2014, about 5 million Americans were suffered with Alzheimer’s disease and this number is projected to be 14 million people by the year 2060. Furthermore, growing investments for the development of structure-based drug designs, increasing research in the field of genomics and proteomics and presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Neuroscience Antibodies and Assays Market is moderately competitive and consists of several major players. In terms of market share, few major players are currently dominating the market. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Inc, Merck KGaA, F. Hoffmann-La Roche, Cell Signaling Technology, Inc, BioLegend, Inc, Abcam Plc, Rockland Immunochemicals, Inc, GenScript and Santa Cruz Biotechnology, Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abcam Plc
  • BioLegend, Inc
  • Bio-Rad Laboratories, Inc
  • F. Hoffmann-La Roche
  • GenScript
  • Thermo Fisher Scientific
  • MORE
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Neurological Diseases
4.2.2 Increasing Research and Development Activities
4.2.3 Growth in the Pharmaceutical and Biotechnology Industries
4.3 Market Restraints
4.3.1 High Cost Associated with the Production of Antibodies
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type
5.1.1 Consumables
5.1.2 Instruments
5.2 By Technology
5.2.1 Immunoassays/Immunochemistry
5.2.2 Molecular Diagnostics
5.2.3 Others
5.3 By End User
5.3.1 Academic and Research Institutes
5.3.2 Pharmaceutical and Biotechnology Companies
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
6.1.1 Thermo Fisher Scientific
6.1.2 Bio-Rad Laboratories, Inc
6.1.3 Merck & Co., Inc (Merck KGaA)
6.1.4 F. Hoffmann-La Roche
6.1.5 Cell Signaling Technology, Inc
6.1.6 BioLegend, Inc
6.1.7 Abcam Plc
6.1.8 Rockland Immunochemicals, Inc
6.1.9 GenScript
6.1.10 Santa Cruz Biotechnology, Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories, Inc
  • Merck & Co., Inc (Merck KGaA)
  • F. Hoffmann-La Roche
  • Cell Signaling Technology, Inc
  • BioLegend, Inc
  • Abcam Plc
  • Rockland Immunochemicals, Inc
  • GenScript
  • Santa Cruz Biotechnology, Inc
Note: Product cover images may vary from those shown
Adroll
adroll